GHK-Cu (50mg Vial) Dosage Protocol

GHK-Cu (50 mg Vial) Dosage Protocol

Quickstart Highlights

GHK-Cu (glycyl-L-histidyl-L-lysine:copper complex) is a naturally occurring copper peptide with documented roles in wound healing, tissue remodeling, and skin regeneration[1][2]. Research demonstrates activity in gene regulation related to collagen synthesis, antioxidant defense, and anti-inflammatory pathways[3][4]. This educational protocol presents practical subcutaneous administration approaches based on clinical practice patterns.

  • Reconstitute: Add 3.0 mL sterile water → 16.67 mg/mL concentration.
  • Typical range: 1.0–2.0 mg per injection (most common protocols use 5 days/week or 3×/week).
  • Easy measuring: At 16.67 mg/mL, 1 unit = 0.01 mL ≈ 167 mcg on a U‑100 insulin syringe.
  • Storage: Lyophilized: store at −20 °C (−4 °F) or below; reconstituted: refrigerate at 2–8 °C (35.6–46.4 °F) and use within 30 days.
  • GHK-Cu 50mg Vial

    Dosing & Reconstitution Guide

    Educational guide for reconstitution and common dosing patterns

    Standard / Conservative Approach (3 mL = 16.67 mg/mL; 5 days/week)

    Week/Phase Dose per Injection Units (per injection) (mL)
    Weeks 1–4 1.0 mg (1000 mcg) 6 units (0.06 mL)
    Weeks 5–8 1.5 mg (1500 mcg) 9 units (0.09 mL)
    Weeks 9–12+ 2.0 mg (2000 mcg) 12 units (0.12 mL)

    Frequency: Inject once daily, 5 days per week subcutaneously[5][6]. This gradual titration allows assessment of individual tolerance while maintaining practical injection volumes. For ≤10‑unit (≤0.10 mL) administrations, consider 30‑ or 50‑unit insulin syringes for improved readability.

    Reconstitution Steps

  • Draw 3.0 mL sterile or bacteriostatic water with a sterile syringe.
  • Inject slowly down the vial wall to minimize foaming.
  • Gently swirl or roll the vial until the peptide fully dissolves (do not shake vigorously).
  • Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
  • Alternative Protocol (3 mL = 16.67 mg/mL; 3× weekly)

    Week/Phase Dose per Injection Units (per injection) (mL)
    Weeks 1–12+ 2.0 mg (2000 mcg) 12 units (0.12 mL)

    Frequency: Inject 2 mg three times per week (e.g., Monday/Wednesday/Friday)[6]. This protocol maintains consistent weekly dosing (~6 mg/week) with less frequent injections.

    Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

    Supplies Needed

    Plan based on an 8–16 week protocol. Calculations shown for both 5 days/week and 3×/week protocols.

  • Peptide Vials (GHK-Cu, 50 mg each):

    • 5 days/week (1.0–2.0 mg/day):
    • 8 weeks (~50 mg total) ≈ 1 vial
    • 12 weeks (~90 mg total) ≈ 2 vials
    • 16 weeks (~130 mg total) ≈ 3 vials
    • 3×/week (2 mg each):
    • 8 weeks (~48 mg) ≈ 1 vial
    • 12 weeks (~72 mg) ≈ 2 vials
    • 16 weeks (~96 mg) ≈ 2 vials
  • Insulin Syringes (U‑100, 29–31 gauge):

    • 5 days/week:
    • Per week: 5 syringes
    • 8 weeks: 40 syringes
    • 12 weeks: 60 syringes
    • 16 weeks: 80 syringes
    • 3×/week:
    • Per week: 3 syringes
    • 8 weeks: 24 syringes
    • 12 weeks: 36 syringes
    • 16 weeks: 48 syringes
  • Sterile or Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.

    • 1 vial protocols: 3 mL1 × 10 mL bottle
    • 2 vial protocols: 6 mL1 × 10 mL bottle
    • 3 vial protocols: 9 mL1 × 10 mL bottle
  • Alcohol Swabs: One for the vial stopper + one for the injection site each administration.

    • 5 days/week:
    • Per week: 10 swabs (2 per injection)
    • 8 weeks: 80 swabs → recommend 1 × 100‑count box
    • 12 weeks: 120 swabs → recommend 2 × 100‑count boxes
    • 16 weeks: 160 swabs → recommend 2 × 100‑count boxes
    • 3×/week:
    • Per week: 6 swabs
    • 8 weeks: 48 swabs → recommend 1 × 100‑count box
    • 12 weeks: 72 swabs → recommend 1 × 100‑count box
    • 16 weeks: 96 swabs → recommend 1 × 100‑count box
  • GHK-Cu 50mg Vial

    View Supplier

    Insulin Syringes

    View Supplier

    Bacteriostatic Water

    View Supplier

    Alcohol Pads

    View Supplier

    Protocol Overview

    Concise summary of common GHK-Cu administration patterns.

  • Goal: Support tissue remodeling, wound healing, and skin regeneration through documented biological pathways[1][2].
  • Schedule: Subcutaneous injections for 8–12 weeks (extend to 16 weeks if desired).
  • Dose Range: 1.0–2.0 mg per injection; frequency 3–5 days per week.
  • Reconstitution: 3.0 mL per 50 mg vial (16.67 mg/mL) provides practical unit measurements.
  • Storage: Lyophilized frozen; reconstituted refrigerated and used within 30 days.